Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Liset Stoletniy"'
Predictors of In-hospital Mortality in Cardiogenic Shock Patients on Vasoactive or Inotropic Support
Autor:
Shuktika Nandkeolyar, Tanya Doctorian, Gary Fraser, Rachel Ryu, Colleen Fearon, David Tryon, Whitney Kagabo, Dmitry Abramov, Christopher Hauschild, Liset Stoletniy, Anthony Hilliard, Antoine Sakr
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 15 (2021)
Background: Though controversial, the short-duration in-patient use of inotropes in cardiogenic shock (CS) remain an ACC/AHA Class IIa indication, and are frequently used in the initial treatment of CS. We evaluated in-patient mortality and effect on
Externí odkaz:
https://doaj.org/article/583e32bfb24443eda809112f578b0782
Publikováno v:
Case Reports in Cardiology, Vol 2021 (2021)
There are several recent reports of tetrahydrocannabinol vaping-related sudden cardiac arrest, and the mechanisms are unclear. We report a unique case of a 19-year-old female who suffered documented prolonged QTc leading to Torsades de pointes and ca
Externí odkaz:
https://doaj.org/article/03ae0386b4e04566849f080cff081810
Publikováno v:
European Journal of Internal Medicine.
Autor:
Jakrin, Kewcharoen, Andrew K, Chang, Purvi, Parwani, Gary, Fraser, Aditya, Bharadwaj, Ahmed, Seliem, Diane, Tran, Liset, Stoletniy, Antoine, Sakr, Dmitry, Abramov
Publikováno v:
Cardiology Research. 13:81-87
Methamphetamines are a common cause of systolic heart failure (HF). There are limited data on the prognosis associated with hospitalizations for decompensated HF in the setting of methamphetamine use. We aimed to evaluate patient characteristics and
Autor:
Chris Hauschild, Rachel Ryu, Dmitry Abramov, Kathia Cordero-Caban, Antoine Sakr, Anthony Hilliard, Adeba Mohammed, Liset Stoletniy, Shuktika Nandkeolyar, Huyentran Tran
Publikováno v:
Journal of Cardiovascular Pharmacology. 78:336-345
Inotropes and inopressors are often first-line treatment in patients with cardiogenic shock. We summarize the pharmacology, indications, and contraindications of dobutamine, milrinone, dopamine, norepinephrine, epinephrine, and levosimendan. We also
Autor:
Liset Stoletniy, Antoine Sakr, Ahmed Seliem, Shuktika Nandkeolyar, Dennis Grewal, Dmitry Abramov, Adeba Mohammad
Publikováno v:
Cardiology Research
Background: Current heart failure guidelines recommend transition of intravenous (IV) diuretics to oral > 24 h prior to hospital discharge. The aim of this study was to determine whether transition to oral diuretics prior to discharge in patients hos
Publikováno v:
Case Reports in Cardiology, Vol 2021 (2021)
Case Reports in Cardiology
Case Reports in Cardiology
There are several recent reports of tetrahydrocannabinol vaping-related sudden cardiac arrest, and the mechanisms are unclear. We report a unique case of a 19-year-old female who suffered documented prolonged QTc leading to Torsades de pointes and ca
Autor:
Rod Partow-Navid, Dante Garcia, Gary E. Fraser, Joshua Coney, Dmitry Abramov, Purvi Parwani, Liset Stoletniy, Antoine Sakr, Dennis Grewal
Publikováno v:
The American Journal of Cardiology. 151:64-69
Despite significant advances in evidence-based treatments for heart failure with reduced ejection fraction (HFrEF), the use of guideline directed medical therapy (GDMT) at recommended doses remains suboptimal. We examine the usage and modification of
Increased sensitivity to ischemic interval of donor hearts with diminished left ventricular function
Autor:
Anees J. Razzouk, Tim P. Martens, David G. Rabkin, Allison B. Davila, Liset Stoletniy, Wendy Shih, Leonard L. Bailey
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:241-247
BACKGROUND Previous studies have demonstrated that carefully selected donor hearts (DHs) with poor left ventricular ejection fraction (EF) may be transplanted with long-term survival equivalent to hearts with normal function. The purpose of this stud
Autor:
Sharon Jung, Liset Stoletniy, Frederik H. Verbrugge, Dmitry Abramov, Anthony Hilliard, Antoine Sakr, Shuktika Nandkeolyar, Saif Ali
The inpatient treatment of acute heart failure (AHF) is aimed at achieving euvolemia, relieving symptoms, and reducing rehospitalization. Adequate treatment of AHF is rooted in understanding the pharmacokinetics and pharmacodynamics of select diureti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982c0b4d0226fdf9c39f2d807a841ef3
https://doi.org/10.1007/s40256-020-00463-5
https://doi.org/10.1007/s40256-020-00463-5